Work

Immunogenicity and disease control induced by a multineoantigen vaccine (ADXS-503) in patients with metastatic non–small cell lung cancer who have progressed on pembrolizumab.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.9042

Authors: Aaron E. Lisberg, Jonathan W. Goldman, Balazs Halmos, Gregory James Gerstner, Neil Morganstein, Charles Michael Farber, Kyoung A Viola Lee, Lydia ML Holtgrewe, Casey Codd, Angelina Bisconte, Theodore Foss, Surya Vangala, Megan Parsi, Andres A. Gutierrez, Suresh S. Ramalingam

Institutions: University of California, Los Angeles, Albert Einstein College of Medicine, Montefiore Medical Center, Illinois CancerCare, Overlook Medical Center, Morristown Medical Center, Yale University, Precision for Medicine (United States), Advaxis (United States), Winship Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281699649

Cites:

Cited by: 2

Related to: 10